Zealand Pharma A/S (ZLDPF) News Today $70.08 -4.05 (-5.46%) As of 06/13/2025 02:26 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock ZLDPF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Brokers Set Expectations for OTCMKTS:ZLDPF FY2026 EarningsJune 14 at 2:17 AM | americanbankingnews.comAnalysts Set Expectations for OTCMKTS:ZLDPF FY2025 EarningsJune 13 at 2:17 AM | americanbankingnews.comCantor Fitzgerald Comments on OTCMKTS:ZLDPF FY2026 EarningsZealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Stock analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Zealand Pharma A/S in a report released on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal anticipates that the company will post earnings of $7.74 per shaJune 12 at 8:49 AM | marketbeat.comFY2025 EPS Forecast for Zealand Pharma A/S Raised by AnalystZealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Equities research analysts at Cantor Fitzgerald lifted their FY2025 EPS estimates for shares of Zealand Pharma A/S in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst P. Agrawal now forecasts that tJune 11 at 8:26 AM | marketbeat.comCantor Fitzgerald Predicts OTCMKTS:ZLDPF FY2025 EarningsZealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Analysts at Cantor Fitzgerald cut their FY2025 earnings per share estimates for Zealand Pharma A/S in a note issued to investors on Monday, May 19th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the company will post earnings of ($4.May 24, 2025 | marketbeat.comZealand CEO: Oral weight loss meds are not the future for treating obesityMay 15, 2025 | seekingalpha.comZealand Pharma A/S (ZLDPF) Projected to Post Quarterly Earnings on ThursdayZealand Pharma A/S (OTCMKTS:ZLDPF) will be releasing earnings on Thursday, May 15. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-15-zealand-pharma-as-stock-1/)May 10, 2025 | marketbeat.comZealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call TranscriptMay 9, 2025 | seekingalpha.comZealand Pharma AS (ZLDPF) Q1 2025 Earnings Call Highlights: Strategic Collaborations and ...May 9, 2025 | finance.yahoo.comInside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambitMay 2, 2025 | cnbc.comZealand Pharma begins mid-stage trial for obesity drug candidate in people with type 2 diabetesApril 24, 2025 | reuters.comZealand Pharma appoints Utpal Singh as CSOApril 23, 2025 | markets.businessinsider.comZealand Pharma Hires Lilly Executive as Biotech Ramps Up in ObesityApril 23, 2025 | msn.comZealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2025April 19, 2025 | finance.yahoo.comZealand Pharma Goes on Hiring Spree as It Gears Up for Obesity Tie-Up With RocheApril 11, 2025 | wsj.comZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 52-Week Low - Here's What HappenedZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 12-Month Low - Here's What HappenedApril 9, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low - Here's WhyZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 12-Month Low - Should You Sell?April 3, 2025 | marketbeat.comGubra’s obesity drug trial success weighs on Zealand Pharma stockApril 2, 2025 | investing.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sees Large Decrease in Short InterestZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 1,241,700 shares, a decline of 31.5% from the February 28th total of 1,811,500 shares. Approximately 1.7% of the company's stock are sold short. Based on an average daily volume of 3,600 shares, the days-to-cover ratio is currently 344.9 days.March 30, 2025 | marketbeat.comZealand Pharma upgraded to Overweight from Equal Weight at Morgan StanleyMarch 21, 2025 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Vicarious Surgical (RBOT), Alkermes (ALKS) and Zealand Pharma (OtherZLDPF)March 18, 2025 | markets.businessinsider.comOTCMKTS:ZLDPF FY2025 EPS Estimate Reduced by William BlairZealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Equities research analysts at William Blair reduced their FY2025 earnings per share estimates for shares of Zealand Pharma A/S in a research report issued on Wednesday, March 12th. William Blair analyst A. Hsieh now anticipates that the company wMarch 15, 2025 | marketbeat.comRoche-Zealand deal is the latest to boost obesity spaceMarch 12, 2025 | msn.comRoche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidateMarch 12, 2025 | cnbc.comRoche Agrees to Develop Weight-Loss Therapy With Zealand PharmaMarch 12, 2025 | msn.comRoche to develop, commercialize obesity drug with Zealand PharmaMarch 12, 2025 | reuters.comZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 1-Year Low - Here's What HappenedZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week Low - Should You Sell?March 11, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 52-Week Low - Here's WhyZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 1-Year Low - What's Next?March 5, 2025 | marketbeat.comZealand Pharma removed from European Conviction List at Goldman SachsMarch 3, 2025 | markets.businessinsider.comZealand Pharma A/S (OTCMKTS:ZLDPF) Upgraded at William BlairWilliam Blair raised Zealand Pharma A/S to a "hold" rating in a research note on Thursday.March 2, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPSZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.78) by $0.19. Zealand Pharma A/S had a negative return on equity of 18.49% and a negative net margin of 1,375.16%.February 21, 2025 | marketbeat.comZealand Pharma A/S (ZLDPF) Q4 2024 Earnings Call TranscriptFebruary 20, 2025 | seekingalpha.comZealand Pharma convenes its Annual General Meeting 2025February 20, 2025 | finance.yahoo.comZealand Pharma A/S (ZLDPF) Projected to Post Quarterly Earnings on TuesdayZealand Pharma A/S (OTCMKTS:ZLDPF) will be releasing earnings before the market opens on Tuesday, February 25, Financial Modeling Prep reports.February 18, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sees Significant Increase in Short InterestZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 1,588,400 shares, an increase of 28.4% from the January 15th total of 1,237,500 shares. Based on an average trading volume of 2,000 shares, the short-interest ratio is presently 794.2 days.February 14, 2025 | marketbeat.comZealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial resultsFebruary 13, 2025 | globenewswire.comZealand Pharma initiated with an Equal Weight at Morgan StanleyFebruary 12, 2025 | markets.businessinsider.comZealand Pharma downgraded to Hold from Buy at SEB EquitiesJanuary 29, 2025 | markets.businessinsider.comCantor Fitzgerald bullish on Zealand Pharma stock, retains Overweight ratingJanuary 24, 2025 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Upgraded to Strong-Buy at Cantor FitzgeraldCantor Fitzgerald upgraded Zealand Pharma A/S to a "strong-buy" rating in a report on Tuesday.January 24, 2025 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Short Interest Up 39.7% in DecemberZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,166,300 shares, an increase of 39.7% from the December 15th total of 835,100 shares. Based on an average daily trading volume, of 2,100 shares, the short-interest ratio is presently 555.4 days.January 15, 2025 | marketbeat.comZealand Seeks to Usurp Wegovy, Zepbound With Obesity DrugJanuary 13, 2025 | msn.comZealand Seeks to Usurp Wegovy, Zepbound With New Obesity DrugJanuary 13, 2025 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Stock Price Down 2.5% - Here's WhyZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Down 2.5% - Time to Sell?January 4, 2025 | marketbeat.comZealand Pharma AS ZLDPFDecember 24, 2024 | morningstar.comJefferies Sticks to Its Buy Rating for Zealand Pharma (ZLDPF)December 20, 2024 | markets.businessinsider.comBTIG Remains a Buy on Zealand Pharma (ZLDPF)December 20, 2024 | markets.businessinsider.comZealand Pharma CEO says Novo's CagriSema data supports monotherapy approach to cagrilintideDecember 20, 2024 | reuters.comZealand Pharma Shares Fall After FDA Pushes Back Bowel-Disease DrugDecember 20, 2024 | marketwatch.comFDA rejects Zealand Pharma's drug for short bowel syndromeDecember 19, 2024 | msn.com Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address ZLDPF Media Mentions By Week ZLDPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLDPF News Sentiment▼1.010.88▲Average Medical News Sentiment ZLDPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLDPF Articles This Week▼101▲ZLDPF Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TEVA News Today SMMT News Today GNMSF News Today ITCI News Today GMAB News Today RDY News Today ASND News Today QGEN News Today MRNA News Today VTRS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ZLDPF) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
